3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 3138553)

Published in Arch Neurol on September 01, 2010

Authors

Joshua Z Willey1, Mitchell S V Elkind

Author Affiliations

1: Department of Neurology, Columbia University, New York, NY 10032, USA. jzw2@columbia.edu

Articles citing this

12/15-Lipoxygenase gene knockout severely impairs ischemia-induced angiogenesis due to lack of Rac1 farnesylation. Blood (2011) 1.53

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation (2011) 1.11

Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis (2013) 1.08

Cholesterol: its regulation and role in central nervous system disorders. Cholesterol (2012) 1.08

The mevalonate pathway in C. elegans. Lipids Health Dis (2011) 0.98

Statin use in giant cell arteritis: a retrospective study. J Rheumatol (2013) 0.98

Statins for the prevention of stroke: a meta-analysis of randomized controlled trials. PLoS One (2014) 0.82

Inhibiting geranylgeranylation increases neurite branching and differentially activates cofilin in cell bodies and growth cones. Mol Neurobiol (2014) 0.82

Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS). Int J Stroke (2013) 0.78

Stroke: do statins improve outcomes after acute ischemic stroke? Nat Rev Neurol (2011) 0.76

Coenzyme Q10 and cognition in atorvastatin treated dogs. Neurosci Lett (2011) 0.76

Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease. J Neuroimmunol (2012) 0.76

Association of Statins with Sensory and Autonomic Ganglionopathy. Front Aging Neurosci (2015) 0.75

Management of intracerebral hemorrhage-use of statins. Vasc Health Risk Manag (2016) 0.75

Articles cited by this

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28

Regulation of the mevalonate pathway. Nature (1990) 18.25

High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA (2001) 5.54

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature (2002) 5.24

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet (2004) 5.19

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation (1998) 5.11

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest (1995) 5.09

Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet (2004) 3.95

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology (2007) 3.67

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology (2010) 3.58

Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56

Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol (2003) 3.54

Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation (2008) 3.48

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology (2008) 3.38

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol (2008) 3.35

Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology (2007) 2.17

Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol (2003) 2.08

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol (2002) 1.79

Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol (2005) 1.76

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med (2007) 1.72

The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke. Int J Stroke (2008) 1.65

Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery (2008) 1.63

Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke (2009) 1.62

Statin treatment and adherence to national cholesterol guidelines after ischemic stroke. Neurology (2006) 1.57

HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol (2000) 1.56

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology (2005) 1.50

Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J Neurol (2009) 1.47

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci (2003) 1.44

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke (2005) 1.44

Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology (2005) 1.43

Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke (2000) 1.40

Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial. Acta Neurol Scand Suppl (2006) 1.30

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis. PLoS One (2008) 1.27

Statin therapy inhibits remyelination in the central nervous system. Am J Pathol (2009) 1.23

Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology (2005) 1.18

Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab (2005) 1.18

Statins as potential therapeutic agents in neuroinflammatory disorders. Curr Opin Neurol (2003) 1.16

Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke (2009) 1.14

The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial. BMC Neurol (2007) 1.10

Statin use and the risk of Parkinson disease. Neurology (2008) 1.10

Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo. J Neurosci (2008) 1.10

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab (2009) 1.08

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke (2008) 1.06

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a. Neurology (2009) 1.05

Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease. Stroke (2001) 1.02

Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke (2009) 1.00

Prior use of statins and outcome in patients with intracerebral haemorrhage. Eur J Neurol (2009) 0.97

Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice. Brain Res (2005) 0.97

Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery (2005) 0.96

Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin. Atherosclerosis (2001) 0.93

Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease. Mov Disord (2007) 0.92

Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis. Biomed Pharmacother (2007) 0.91

Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia. Heart (2003) 0.90

Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats. Neurosci Lett (2006) 0.88

Nitric oxide specifically inhibits integrin-mediated platelet adhesion and spreading on collagen. J Thromb Haemost (2008) 0.86

Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy. Arterioscler Thromb Vasc Biol (2009) 0.84

Statins as acute-stroke treatment. Int J Stroke (2006) 0.84

Statins to treat multiple sclerosis: friend or foe? Neurology (2008) 0.76

Articles by these authors

(truncated to the top 100)

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56

Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48

Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 2.43

Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34

Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33

Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30

An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26

Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17

Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13

Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00

Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97

Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96

Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project. Stroke (2012) 1.91

Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke (2008) 1.91

Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91

Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77

Infectious burden and cognitive function: the Northern Manhattan Study. Neurology (2013) 1.77

Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol (2009) 1.74

Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care (2008) 1.69

Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke (2012) 1.65

Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Circulation (2013) 1.61

Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol (2011) 1.61

CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55

Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol (2009) 1.52

Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol (2013) 1.52

Pulsatile and steady components of blood pressure and subclinical cerebrovascular disease: the Northern Manhattan Study. J Hypertens (2015) 1.48

Prevalence and quality of endodontic treatment in the Northern Manhattan elderly. J Endod (2007) 1.45

Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function. Hypertension (2012) 1.41

Diet soft drink consumption is associated with an increased risk of vascular events in the Northern Manhattan Study. J Gen Intern Med (2012) 1.37

Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med (2014) 1.34

The risk of paradoxical embolism (RoPE) study: initial description of the completed database. Int J Stroke (2012) 1.32

Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke (2012) 1.32

Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke (2004) 1.32

Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke (2009) 1.32

Construct validity of cognitive reserve in a multiethnic cohort: The Northern Manhattan Study. J Int Neuropsychol Soc (2009) 1.30

Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2012) 1.28

Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. Am J Epidemiol (2010) 1.26

Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke (2006) 1.25

The vascular effects of infection in Pediatric Stroke (VIPS) Study. J Child Neurol (2011) 1.23

Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart (2012) 1.23

Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J (2008) 1.22

Stochastic approximation with virtual observations for dose-finding on discrete levels. Biometrika (2009) 1.21

Septal pouch in the left atrium and risk of ischemic stroke. JACC Cardiovasc Imaging (2010) 1.20

Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). Atherosclerosis (2011) 1.17

The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol. Stroke (2013) 1.14

Social determinants of physical inactivity in the Northern Manhattan Study (NOMAS). J Community Health (2010) 1.14

Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke (2013) 1.14

Intravenous thrombolytic treatment of acute ischemic stroke associated with left atrial myxoma: a case report. J Stroke Cerebrovasc Dis (2007) 1.13

Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis (2009) 1.13

Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis (2007) 1.13

Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke (2012) 1.13

Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. Eur J Heart Fail (2010) 1.12

Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke (2013) 1.11

Outpatient training in neurology: history and future challenges. Neurology (2006) 1.10

Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09

Early depressed mood after stroke predicts long-term disability: the Northern Manhattan Stroke Study (NOMASS). Stroke (2010) 1.09

The growing problem of stroke among young adults. Curr Cardiol Rep (2013) 1.09

Daytime sleepiness and risk of stroke and vascular disease: findings from the Northern Manhattan Study (NOMAS). Circ Cardiovasc Qual Outcomes (2012) 1.08

LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. JACC Cardiovasc Imaging (2013) 1.08

Recent developments regarding human immunodeficiency virus infection and stroke. Cerebrovasc Dis (2012) 1.07

Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome. Ann Neurol (2014) 1.06

Endothelial dysfunction is associated with carotid plaque: a cross-sectional study from the population based Northern Manhattan Study. BMC Cardiovasc Disord (2006) 1.05

Lipids and carotid plaque in the Northern Manhattan Study (NOMAS). BMC Cardiovasc Disord (2009) 1.04

The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease. J Neurosurg (2009) 1.04

Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet (2015) 1.03

Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke (2011) 1.03

Adiponectin and carotid intima-media thickness in the northern Manhattan study. Stroke (2011) 1.02

Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease. Circulation (2010) 1.01

Alterations in plasma complement levels after human ischemic stroke. Neurosurgery (2006) 1.00

Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume: the northern Manhattan study. Stroke (2011) 1.00

Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. J Neurosurg (2009) 1.00

Dietary total fat intake and ischemic stroke risk: the Northern Manhattan Study. Neuroepidemiology (2009) 0.99

Impact of delayed transfer of critically ill stroke patients from the Emergency Department to the Neuro-ICU. Neurocrit Care (2010) 0.99

Radiographic measures of chronic periodontitis and carotid artery plaque. Stroke (2005) 0.98

The contribution of HIV infection to intracranial arterial remodeling: a pilot study. Neuropathology (2012) 0.97

A questionable cause of intracerebral hemorrhage. JAMA Neurol (2013) 0.97

Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study. Arch Neurol (2012) 0.97

Cardiovascular health status among Caribbean Hispanics living in Northern Manhattan and Ecuadorian natives/mestizos in rural coastal Ecuador: a comparative study. J Community Health (2013) 0.97

Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther (2011) 0.95

Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan Study. Am Heart J (2011) 0.95

Snoring and insomnia are not associated with subclinical atherosclerosis in the Northern Manhattan Study. Int J Stroke (2010) 0.95

Ethnic differences in carotid artery diameter and stiffness: the Northern Manhattan Study. Atherosclerosis (2011) 0.95

High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study. Stroke (2014) 0.95

Relationship of multidirectional myocardial strain with radial thickening and ejection fraction and impact of left ventricular hypertrophy: a study in a community-based cohort. Echocardiography (2013) 0.94

Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms. Int J Stroke (2011) 0.94

Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). Neurology (2014) 0.94

Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox. Ann Epidemiol (2012) 0.93

Association between sleep duration and the mini-mental score: the Northern Manhattan study. J Clin Sleep Med (2013) 0.93

Reported alcohol consumption and cognitive decline: The northern Manhattan study. Neuroepidemiology (2006) 0.91

Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population. J Nutr (2013) 0.90

Moderate alcohol consumption is associated with better endothelial function: a cross sectional study. BMC Cardiovasc Disord (2009) 0.90

Sleep duration is associated with white matter hyperintensity volume in older adults: the Northern Manhattan Study. J Sleep Res (2014) 0.90

Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study. Age Ageing (2013) 0.89

Ethnic differences in aortic valve thickness and related clinical factors. Am Heart J (2010) 0.89

Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study. Cerebrovasc Dis (2014) 0.88

The metabolic syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study. J Cardiometab Syndr (2007) 0.88